Replimune's drug for advanced skin cancer fails to win FDA nod again Reuters
By Padmanabhan Ananthan and Sruthi Narasimha Chari April 10 (Reuters) – The U.S. Food and Drug Administration on Friday declined to approve Replimune’s drug for advanced skin cancer, citing insuffici